{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:36:52Z","timestamp":1794353812324,"version":"4.9.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.euroneuro.2005.06.003","type":"journal-article","created":{"date-parts":[[2005,7,18]],"date-time":"2005-07-18T14:47:44Z","timestamp":1121698064000},"page":"71-77","source":"Crossref","is-referenced-by-count":56,"title":["Bipolar mania and plasma amino acids: Increased levels of glycine"],"prefix":"10.1016","volume":"16","author":[{"given":"R.","family":"Hoekstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fekkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.M.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pepplinkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tuinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2005.06.003_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1176\/ajp.150.11.1731","article-title":"Plasma and platelet excitatory amino acids in psychiatric disorders","volume":"150","author":"Altamura","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"A comprehensive psychopathological rating scale","volume":"271","author":"\u00c5sberg","year":"1978","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib3","first-page":"832","article-title":"Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations","volume":"21","author":"Castillo","year":"2000","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-003-1709-2","article-title":"The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia","volume":"174","author":"Coyle","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.06.003_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1568007024606212","article-title":"Ionotropic glutamate receptors as therapeutic targets in schizophrenia","volume":"1","author":"Coyle","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disorders"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.06.003_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D'Souza","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2005.06.003_bib8","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1073\/pnas.94.9.4757","article-title":"The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-triphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and biphosphates","volume":"94","author":"Dixon","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib9","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1073\/pnas.95.14.8363","article-title":"Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex","volume":"95","author":"Dixon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.euroneuro.2005.06.003_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00004714-200304000-00011","article-title":"Antidepressant properties of anticonvulsant drugs for bipolar disorder","volume":"23","author":"Ernst","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.178.4059.414","article-title":"Brain serotonin content: physiological regulation by plasma neutral amino acids","volume":"178","author":"Fernstrom","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0378-4347(95)00111-U","article-title":"Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated derivatization with o-phtaldialdehyde","volume":"669","author":"Fekkes","year":"1995","journal-title":"J. Chromatogr., B"},{"issue":"5","key":"10.1016\/j.euroneuro.2005.06.003_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0091-3057(82)90476-2","article-title":"Brain serotonergic activity and plasma amino acid levels in genetically obese Zucker rats","volume":"17","author":"Finkelstein","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2005.06.003_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(02)00070-8","article-title":"Principal components of mania","volume":"76","author":"Gonzalez-Pinto","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.59.6.521","article-title":"Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia","volume":"59","author":"Heckers","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","article-title":"Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis","volume":"55","author":"Heresco-Levy","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2005.06.003_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1781(01)00282-7","article-title":"Effect of ECT treatment on biopterin and large neutral amino acids in severe, medication resistant depression","volume":"103","author":"Hoekstra","year":"2001","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00441418","article-title":"Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid","volume":"148","author":"Iinuma","year":"1988","journal-title":"Eur. J. Pediatr."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2005.06.003_bib20","first-page":"89","article-title":"Glycine modulators in schizophrenia","volume":"66","author":"Javitt","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib21","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","article-title":"Amelioration of negative symptoms in schizophrenia by glycine","volume":"151","author":"Javitt","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0006-3223(98)00237-6","article-title":"Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors","volume":"45","author":"Javitt","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S1461145701002553","article-title":"Tryptophan depletion in lithium-stabilized patients with affective disorder","volume":"4","author":"Johnson","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.euroneuro.2005.06.003_bib24","first-page":"15","article-title":"The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders","volume":"64","author":"Ketter","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2005.06.003_bib25","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 9","key":"10.1016\/j.euroneuro.2005.06.003_bib26","first-page":"5","article-title":"Overview of the mechanism of action of lithium in the brain: fifty-year update","volume":"61","author":"Lenox","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0278-5846(95)00106-6","article-title":"Neutral amino acid availability in two major psychiatric disorders","volume":"19","author":"Lucca","year":"1995","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(90)90136-S","article-title":"Amino acid pattern in schizophrenia: some new findings","volume":"32","author":"Macciardi","year":"1990","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00226-3","article-title":"Serotonin and bipolar disorder","volume":"66","author":"Mahmood","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression","volume":"53","author":"Manji","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-0327(90)90091-L","article-title":"Changes in platelet 5-hydroxytryptamine uptake in mania","volume":"19","author":"Meagher","year":"1990","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","article-title":"Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex","volume":"168","author":"Michael","year":"2003","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.euroneuro.2005.06.003_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1528-1157.1980.tb04310.x","article-title":"Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid","volume":"21","author":"Mortensen","year":"1980","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib34","first-page":"99","article-title":"Tryptophan depletion, serotonin, and depression: where do we stand?","volume":"37","author":"Neumeister","year":"2003","journal-title":"Psychopharmacol. Bull."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0924-977X(03)00070-1","article-title":"Effects of chronic lithium and sodium valproate on concentrations of brain amino acids","volume":"13","author":"O'Donnell","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00433732","article-title":"Erythrocyte glycine in depressed, hypomanic, and euthymic bipolar patients treated with lithium carbonate","volume":"78","author":"Peselow","year":"1982","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.06.003_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/seiz.1999.0267","article-title":"Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures","volume":"8","author":"Petroff","year":"1999","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0301-0082(02)00017-5","article-title":"Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders","volume":"67","author":"Pralong","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(90)90003-N","article-title":"Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects","volume":"34","author":"Rao","year":"1990","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.06.003_bib40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1176\/ajp.136.5.672","article-title":"Amino acids in bipolar affective disorders: increased glycine levels in erythrocytes","volume":"136","author":"Rosenblatt","year":"1979","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.06.003_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1781(82)90008-7","article-title":"Elevation of erythrocyte glycine levels during lithium treatment of affective disorders","volume":"6","author":"Rosenblatt","year":"1982","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/ajp.140.4.396","article-title":"CSF monoamine metabolites in mania","volume":"140","author":"Swann","year":"1983","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2005.06.003_bib43","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1176\/ajp.153.11.1460","article-title":"d-Fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity","volume":"153","author":"Thakore","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000054937","article-title":"Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine","volume":"44","author":"Tortorella","year":"2001","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00965013","article-title":"Antagonism of phencyclidine-induced hyperactivity by glycine in mice","volume":"11","author":"Toth","year":"1986","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.euroneuro.2003.09.002","article-title":"Atypical antipsychotics and the relevance of glutamate and serotonin","volume":"14","author":"Van der Heijden","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00702-004-0200-5","article-title":"Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?","volume":"112","author":"Van der Heijden","year":"2005","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.euroneuro.2005.06.003_bib48","first-page":"125","article-title":"Serotonin and amino acids; partners in delirium pathophysiology?","volume":"5","author":"Van der Mast","year":"2000","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"10.1016\/j.euroneuro.2005.06.003_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-979183","article-title":"Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects","volume":"32","author":"Verhoeven","year":"1999","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2005.06.003_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0009-9120(83)80006-X","article-title":"The influence of anticonvulsants on fasting plasma ammonia and amino acid levels","volume":"16","author":"Verity","year":"1983","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.06.003_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02815111","article-title":"Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone Balb\/c mice","volume":"27","author":"Vriend","year":"1996","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.06.003_bib53","first-page":"35","article-title":"Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders","volume":"36","author":"Zarate","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2005.06.003_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1196\/annals.1300.017","article-title":"Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system","volume":"1003","author":"Zarate","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0500101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0500101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T12:27:36Z","timestamp":1548332856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X0500101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0924977X0500101X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.06.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}